Woburn medical device firm Bio2 Technologies Inc. has taken in $1.1 million in equity financing, according to a regulatory filing.
The company makes tissue engineering scaffolds, intended for orthopedic use, based on its cross-linked microstructure (CLM) that Bio2 licenses from Geo2 Technologies Inc.
Geo2 Technologies, located at the same Woburn address, is a materials science firm that uses its patented CLM technology in both automotive and industrial applications, according to the company’s website.
The CLM technology enables Bio2 to develop scaffolds that have high porosity and strength. Bio2 notes on its website that CLM also enables the company to provide a load-bearing material to remodel bone, instead of replacing it.